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A B S T R A C T
Staphylococcus Lugdunensis is a rare but potentially aggressive pathogen in the family of coagulase
negative staphylococcus (CoNS). It can cause a wide variety of infections ranging from superﬁcial skin to
fulminant infections like endocarditis. Both native and prosthetic valve endocarditis due to S. lugdunensis
have been documented in the English literature. Eight cases of pacemaker lead endocarditis due to S.
lugdunensis have been described so far. We present the ninth case of pacemaker lead and ﬁrst case of
automatic implantable cardioverter deﬁbrillator (AICD) lead endocarditis due to S. lugdunensis.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Staphylococcus lugdunensis is a rare but potentially aggressive
pathogen in the family of coagulase-negative staphylococci
(CoNS).1 It can cause a wide variety of infections ranging from
superﬁcial skin infections to fulminant infections like endocardi-
tis.2 Both native and prosthetic valve endocarditis due to S.
lugdunensis have been documented in the English literature.1–4
Eight cases of pacemaker lead endocarditis due to S. lugdunensis
have been described so far.5–8 We present the ninth case of
pacemaker lead and ﬁrst case of automatic implantable cardio-
verter deﬁbrillator (AICD) lead endocarditis due to S. lugdunensis.
The young age of our patient and the large vegetation size, both of
which may be prognostic indicators, makes this case unique
amongst similar cases reported. Also, since AICDs and pacemakers
aremore commonly inserted than ever before, clinicians need to be
aware of the catastrophic complications associated with them.9
2. Case report
A 41-year-old morbidly obese African-American male with an
AICD presented to the emergency department with complaints of* Corresponding author. Tel.: +1 216 778 7800; fax: +1 216 778 8227.
E-mail address: dgulati@metrohealth.org (D. Gulati).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.12.008subjective fever and right-sided pleuritic chest pain for a few days.
He had a past medical history of non-ischemic dilated cardiomy-
opathy, left ventricular ejection fraction of 25%, and frequent
episodes of non-sustained ventricular tachycardia (NSVT) that led
to the placement of an AICD. He also had a history of hypertension,
diabetes mellitus type 2, stage V chronic kidney disease,
obstructive sleep apnea, asthma, and gout. His last hemodialysis
exchange had been 1 day prior to presentation, through a
permacatheter in the left subclavian vein.
In the emergency department, the patient was hypotensive (78/
51mmHg), tachycardic (101 beats perminute), and tachypneic (23
respirations per min), with normal oxygen saturation and
temperature. A complete blood count revealed hemoglobin of
6.8 g/dl and hematocrit of 22.8%, platelet count of 238  109/l, and
a leukocyte count of 7.9  109/l with 64% segmented neutrophils,
16% lymphocytes, 15% monocytes, and 5% eosinophils. A basic
metabolic panel revealed glucose of 156 mg/dl, calcium of 7.4 mg/
dl, blood urea nitrogen of 45 mg/dl, and creatinine of 11.63 mg/dl.
Chest X-ray showed mild interstitial prominence consistent with
mild acute decompensated heart failure. The initial evaluation was
thought to be sepsis, with the likely source of infection being the
permacatheter, as a result of frequent manipulation for hemodial-
ysis. Due to this strong clinical suspicion, the permacatheter was
removed and the tip sent for culture, and a temporary dialysis
catheter was placed. In addition, two sets of blood cultures were
drawn and the patient was empirically started on vancomycinses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Echocardiogram showing vegetations on ventricular AICD lead.
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A. Chopra et al. / International Journal of Infectious Diseases 14S (2010) e291–e293e292because of penicillin allergy. Three units of packed red blood cells
were also transfused.
Three consecutive sets of blood cultures drawn 24 h apart and
all cultures done in the ﬁrst 5 days of admission grew S.
lugdunensis, including the one from the permacatheter tip. This
organism was differentiated from other CoNS with the help of the
PYR (L-pyrrolidonyl-b-naphthylamide) test and ornithine decar-
boxylate test, both of which were positive for S. lugdunensis. The
patient was thought to be at high risk for an AICD lead infection, so
a transthoracic echocardiogram (TTE)was performed on day 3; this
showed no vegetations, and vancomycin was continued. The
patient started a spiking temperature of up to 40 8C despite
vancomycin therapy. Due to the persistent clinical suspicion of an
AICD lead infection, a transesophageal echocardiogram (TEE) was
performed on day 6, which showed large vegetations measuring
36 mm  21 mm, 19 mm  15 mm, and 17 mm  4 mm attached
to the right atrial pacemaker lead, ventricular AICD lead (Figure 1),
and tricuspid valve, respectively. Gentamicin and rifampin were
added to the vancomycin regimen. Bacteremia cleared after day 5
of admission. However, due to the large size of the vegetations and
virulent nature of the causative infectious agent, immediate
surgical extraction of the AICD lead apparatus and vegetations was
recommended. The patient’s ﬂuctuating hemodynamic instability,
including episodes of hypotension and tachycardia, delayed the
surgery for 15 days and the patient was continued on the antibiotic
regimen. A TEE was performed on day 21 to reevaluate the
vegetation, which found an increase in the dimensions of the right
atrial lead vegetation to 41 mm  21 mm and right ventricular
lead vegetation to 39 mm  15 mm. On day 27, the patient was felt
to be stable enough to undergo surgery, but the procedure was
prematurely abandoned because he became hemodynamically
unstable in the operating room. Three days later the patient
successfully underwent the removal of the infected AICD lead and
vegetations. His postoperative course was uneventful and repeat
blood cultures during the following week were negative. A new
AICD was placed on day 37 and the patient was discharged to a
skilled-care nursing facility. The patient ﬁnished 6 weeks of
vancomycin after the new AICD placement and has done well since
discharge.
3. Discussion
CoNS are a major cause of infections, including infective
endocarditis, in patients with indwelling catheters and foreign
bodies.1,10,11 Of the CoNS species, S. lugdunensis has been
considered more pathogenic than most others, causing severe
complications in native and prosthetic valve endocarditis includ-
ing valvular abscess, rupture, and treatment failure.1–4,10 It has also
A. Chopra et al. / International Journal of Infectious Diseases 14S (2010) e291–e293 e293been shown to cause pacemaker lead endocarditis. Reasons for the
increased pathogenicity of S. lugdunensis are still unclear.
We reviewed the literature using the PubMed database for all
cases of pacemaker and AICD lead endocarditis due to S.
lugdunensis prior to June 2009, and to our knowledge only eight
previous cases of pacemaker lead and no case of AICD lead
endocarditis have been reported. Our case constitutes the ﬁrst case
of AICD lead and ninth case of intracardiac lead (ICL) endocarditis
combined, due to S. lugdunensis. Our case illustrates important
discussion points.
The mean age at presentation for ICL endocarditis due to S.
lugdunensis has been reported to be 66 years (Table 1), while our
patient was only 41 years old. This early presentation can be
explained by the multiple co-morbidities in our patient including
diabetes and stage V chronic kidney disease requiring hemodialy-
sis, thus predisposing him to nosocomial infections. This ﬁnding
also correlates with earlier reports where severe S. lugdunensis
infections including fatal sepsis have been described in patients
with underlying chronic illnesses and immunosuppression.1,12
CoNS should not be dismissed as a culture contaminant,
especially in patients with indwelling catheters and pace-
makers.2,10 Although CoNS infections usually have an indolent
course, species identiﬁcation is important because of the fulminant
course seen in S. lugdunensis infections, as in our patient. Also
infective endocarditis should be considered in the differential
diagnosis of patients with an ICL who grow CoNS in their blood.
TEE remains the gold standard for identiﬁcation of intracardiac
vegetations. The sensitivity of TEE in demonstrating lead vegeta-
tions is 96%, while for TTE is only 30%.11,12 As exempliﬁed in our
case, initial TTE can lead to false-negative results, which can cause
delays in appropriate management. Therefore when a clinical
suspicion for infective endocarditis is high, TEE should preferably
be considered as the initial imaging modality.13
The most important point illustrated by our case is that the
surgical extraction of lead apparatus remains the gold standard in
management. As in our case, the delay in the initial surgical
management due to the patient’s ﬂuctuating hemodynamic status
saw an increase in the size of the vegetations despite optimal
medical management for 2 weeks. Therefore, initial surgical lead
extraction should be performed without delay in patients with ICL
endocarditis due to S. lugdunensis. This is in agreement with the
American Heart Association scientiﬁc statement on non-valvular
cardiovascular device-related infections.13
It is noted that all nine cases underwent surgery. Out of the nine
patients, eight patients were alive at least 1 month after surgery
and one death was reported (unreported cause) (Table 1). Our
patient did well postoperatively, and is currently under the
constant outpatient care of the cardiothoracic and infectious
disease teams. Although the overall prognosis of appropriately
managed patients appears to be good, it is difﬁcult to conclude due
to the limited data available.4. Conclusions
Staphylococcus lugdunensis is one of the most virulent organ-
isms in the family of CoNS and therefore should not be ignored as a
culture contaminant, especially in patients with indwelling
catheters, intracardiac devices, and multiple co-morbidities. Once
a patient with an intracardiac lead is known to have grown S.
lugdunensis in their blood culture, the initial imaging modality
should preferably be TEE to rule out infective endocarditis. For
patients identiﬁed to have lead vegetations, surgical lead extrac-
tion appears to be the management of choice, and can be
performed without delay. Above all, as intravascular devices
become more prevalent, the rates of rare and catastrophic
infections like S. lugdunensis endocarditis will likely increase and
clinicians need to be more vigilant.
5. Conﬂict of interest
No conﬂict of interest to declare.
References
1. Frank KL, Del Pozo JL, Patel R. From clinical microbiology to infection patho-
genesis: how daring to be different works for Staphylococcus lugdunensis. Clin
Microbiol Rev 2008;21:111–33.
2. Seenivasan MH, Yu VL. Staphylococcus lugdunensis endocarditis—the hidden
peril of coagulase-negative Staphylococcus in blood cultures. Eur J ClinMicrobiol
Infect Dis 2003;22:489–91.
3. Van Hoovels L, De Munter P, Colaert J, Surmont I, Van Wijngaerden E, Peerter-
mans WE, et al. Three cases of destructive native valve endocarditis caused by
Staphylococcus lugdunensis. Eur J Clin Microbiol Infect Dis 2005;24:149–52.
4. Renzulli A, Della Corte A, Torella M, Dialetto G, Cotrufo M. Mitral and aortic
valve endocarditis due to Staphylococcus lugdunensis. Tex Heart Inst J
2000;27:67–9.
5. Anguera I, Del Rio A, Miro JM, Matinez-Lacasa X, Marco F, Guma JR, et al.
Staphylococcus lugdunensis infective endocarditis: description of 10 cases and
analysis of native valve, prosthetic valve, and pacemaker lead endocarditis
clinical proﬁles. Heart 2005;91:e10.
6. Seifert H, Oltmanns D, Becker K, Wisplinghoff H, von Eiff C. Staphylococcus
lugdunensis pacemaker-related infection. Emerg Infect Dis 2005;11:1283–6.
7. LagunoM,Miro O, Font C, de la Sierra A. Pacemaker-related endocarditis. Report
of 7 cases and review of the literature. Cardiology 1998;90:244–8.
8. Bobin S, Durand-Dubief A, Bouhour D, Kirkorian G, Vandenesch F, Etienne J, et al.
Pacemaker endocarditis due to Staphylococcus lugdunensis: report of two cases.
Clin Infect Dis 1999;28:404–5.
9. Pfeiffer D, JungW, FehskeW, Korte T, Manz M, Moosdorf R, et al. Complications
of pacemaker deﬁbrillator devices: diagnosis and management. Am Heart J
1994;127:1073–80.
10. Von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-
negative staphylococci. Lancet Infect Dis 2002;2:677–85.
11. Karchmer AW, Longworth DL. Infections of intracardiac devices. Cardiol Clin
2003;21:253–71. vii.
12. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and
management of infections involving implantable electrophysiologic cardiac
devices. Ann Intern Med 2000;133:604–8.
13. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, et al.
Nonvalvular cardiovascular device-related infections. Circulation 2003;108:
2015–31.
